PAR paradigm biopharmaceuticals limited..

Ann: Paradigm Secures Ethics Approval for Phase 3 Trial, page-24

  1. 869 Posts.
    lightbulb Created with Sketch. 1231
    PAR Broker Data
    Retail investor accumulation has been growing over the last year. However, the accumulation chart has been near neutral over the past month, signaling a potential pivot.
    This could indicate increasing interest from professional investors if they start buying from retail investors.

    https://hotcopper.com.au/data/attachments/6833/6833238-cbb502466b9dfb2d54c14ce965ed5f62.jpg


    Investment banks are not in yet - their sentiment remains negative, with heavy selling in December and January. If they come back, it could push the price significantly above the current resistance level at 0.65.

    https://hotcopper.com.au/data/attachments/6833/6833241-ea269895542cc3425817aa249d7f6945.jpg


    Here’s the price level and broker participation on the buy and sell side over the last month.

    https://hotcopper.com.au/data/attachments/6833/6833251-13447fb60e3aedc95fd61c2ce954a640.jpg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $116.8M
Open High Low Value Volume
30.0¢ 30.5¢ 29.5¢ $56.35K 188.1K

Buyers (Bids)

No. Vol. Price($)
1 9339 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 14285 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.